HIF1A and cancer: Hypoxia changes mediated by HIF-1α and elevated ROS levels enhance the differentiation, recruitment, survival, and immunosuppressive functions of MDSCs, fostering a tumor-supportive microenvironment that promotes cancer progression, immune evasion, and therapy resistance.